Antiseizure medication selection and retention for adult onset focal epilepsy in a Swedish health service region: A population‐based cohort study

Abstract

Objective

Historically, approximately half of those with newly diagnosed epilepsy have responded to and tolerated the first antiseizure medication (ASM), but there are few contemporary real-world data. Third-generation ASMs have improved tolerability and are increasingly used according to prescription data. We aimed to describe current ASM selection and retention in adult onset focal epilepsy in western Sweden.

Methods

A multicenter retrospective cohort study was performed at five public neurology care providers in western Sweden (nearly complete coverage in the area). We reviewed 2607 ...

Seguir leyendo →
0

Neurodevelopment of babies born to mothers with epilepsy: A prospective observational cohort study

Abstract

Objective

Despite widespread monotherapy use of lamotrigine or levetiracetam during pregnancy, prospectively collected, blinded child development data are still limited. The NaME (Neurodevelopment of Babies Born to Mothers With Epilepsy) Study prospectively recruited a new cohort of women with epilepsy and their offspring for longitudinal follow-up.

Methods

Pregnant women of <21 weeks gestation (n = 401) were recruited from 21 hospitals in the UK. Data collection occurred during pregnancy (recruitment, trimester 3) and at 12 and 24 months of age. The primary outcome was blinded assessment of ...

Seguir leyendo →
0

Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures

Abstract

Objective

Higher levels of biochemical blood markers of brain injury have been described immediately after tonic–clonic seizures and in drug-resistant epilepsy, but the levels of such markers in epilepsy in general have not been well characterized. We analyzed neurofilament light (NfL), glial fibrillary acidic protein (GFAP), and tau in a regional hospital-based epilepsy cohort and investigated what proportion of patients have levels suggesting brain injury, and whether certain epilepsy features are associated with high levels.

Methods

Biomarker levels were measured in 204 patients ...

Seguir leyendo →
0

Machine learning using multimodal clinical, electroencephalographic, and magnetic resonance imaging data can predict incident depression in adults with epilepsy: A pilot study

Abstract

Objective

This study was undertaken to develop a multimodal machine learning (ML) approach for predicting incident depression in adults with epilepsy.

Methods

We randomly selected 200 patients from the Calgary Comprehensive Epilepsy Program registry and linked their registry-based clinical data to their first-available clinical electroencephalogram (EEG) and magnetic resonance imaging (MRI) study. We excluded patients with a clinical or Neurological Disorders Depression Inventory for Epilepsy (NDDI-E)-based diagnosis of major depression at baseline. The NDDI-E was used to detect incident depression over a median ...

Seguir leyendo →
0

Catamenial epilepsy occurence and patterns in a mixed population of women with epilepsy

Abstract

Abstract

We aimed to evaluate the occurrence and distribution of patterns of catamenial epilepsy in a heterogenous cohort of women with epilepsy on no hormonal therapies, enrolled in a prospective, observational study. The primary aim of the study was pregnancy rate in women with epilepsy with no prior reproductive problems. In this analysis, we included women who recorded ≥one menstrual cycle with ≥one seizure. We measured progesterone concentrations for 1-3 cycles. We defined catamenial patterns as ≥two-fold average daily seizure frequency ...

Seguir leyendo →
0

In‐hospital outcomes in patients with and without epilepsy diagnosed with COVID‐19 – A cohort study

Abstract

Objectives

COVID-19 is associated with mortality in those with comorbidities. The aim of this study was to evaluate in-hospital outcomes in patients with COVID-19 with and without epilepsy.

Methods

We conducted a retrospective study of patients with COVID-19 admitted in a multicenter health system between March 15, 2020 and May 17, 2021. Patients with epilepsy were identified using a validated ICD-9-CM/ICD-10-CM case definition. Logistic regression models and Kaplan-Meier analyses were conducted for mortality and non-routine discharges (i.e., not discharged home). An ordinary least ...

Seguir leyendo →
0

Increasing challenges to trial recruitment and conduct over time

Abstract

Objective

To evaluate how the challenges in the recruitment and retention of participants in clinical trials for focal-onset epilepsy have changed over time.

Methods

In this systematic analysis of randomized clinical trials of adjunct antiseizure medications for medication-resistant focal-onset epilepsy, we evaluated how the number of participants, sites, and countries has changed since the first such trial in 1990. We also evaluated the proportion of participants who completed each trial phase and their reasons for early trial exit. We analyzed these trends using ...

Seguir leyendo →
0

Birth outcomes in pregnant women with epilepsy: A Nationwide multicenter study from Türkiye

Abstract

Objective

The present study was aimed at investigating the effects of anti-seizure medications (ASMs), patient demographic characteristics, and the seizure type and frequency on the development of congenital malformations (CMs) in the infants of pregnant women with epilepsy (PWWE).

Methods

PWWE followed up at the neurology outpatient clinic of 21 centers between 2014 and 2019 were included in this prospective study. The follow-up of PWWE was conducted using structured, general pregnant follow-up forms prepared by the Pregnancy and Epilepsy Study Committee. The newborns ...

Seguir leyendo →
0
Página 42 de 242 «...1020304041424344...»